New Jersey Assembly Bill 4052
Session 220
Establishes three-year sickle cell disease pilot program; appropriates $10,200,000.*
Active
Passed Senate on Dec 21, 2023
Sponsors
6 Sponsors
Verlina Reynolds-Jackson
Conaway, Herb
Raj Mukherji
Linda S. Carter
Shirley K. Turner
Andrew Zwicker
First Action
May 19, 2022
Latest Action
Dec 21, 2023
Origin Chamber
Assembly
Type
Bill
Bill Number
4052
State
New Jersey
Session
220
Conaway, Herb
grade
Primary
Atkins, Reginald W.
Cosponsor
Burgess, Renee C.
Cosponsor
Jaffer, Sadaf F.
Cosponsor
Moen, William F.
Cosponsor
Sampson, William B.
Cosponsor
Assembly votes are unavailable for this bill.
Summary
Unavailable
Legislative Fiscal Estimate 6/26/23; 1R
Statement AHE 6/5/23
Statement AAP 6/22/23 1R
Statement SBA 11/30/23
Sort by most recent
12/21/2023
Senate
Passed Senate (Passed Both Houses) (35-0)
12/21/2023
Senate
Substituted for S2710 (1R)
11/30/2023
Senate
Reported out of Senate Committee, 2nd Reading
11/27/2023
Senate
Received in the Senate, Referred to Senate Budget and Appropriations Committee
06/30/2023
Assembly
Passed Assembly (75-0-0)
06/22/2023
Assembly
Reported out of Assembly Committee, 2nd Reading
06/05/2023
Assembly
Reported out of Assembly Committee with Amendments and Referred to Assembly Appropriations Committee
05/19/2022
Assembly
Introduced in the Assembly, Referred to Assembly Health Committee
Sources
NJ Legislature
Open States
Record Created
May 20, 2022 12:05:36 AM
Record Updated
Dec 22, 2023 4:09:12 AM